🌙
Average Insider
Where insiders trade, we follow
🔍
☰
🏠 Home
🔍 Search
🏢 Companies
📊 Cluster Buys
📄 Filings Search
💰 Earnings Calendar
📧 Newsletters
📝 Sign Up
🔐 Sign In
Buy/Sell Ratio
›
February 2026
›
Healthcare Sector
Insider Buy/Sell Details for the Healthcare Sector — February 2026
Extreme outlier transactions (>3σ) are excluded.
Show All Data
Ratio
0.1:1
Daily Buy & Sell Volume
Log Scale
Transactions
(1586)
All (1586)
Buys (171)
Sells (1415)
Company
Insider
Title
Sort by
Date (newest)
Total Value
% of Holdings
Company Name
Apply
Pacira BioSciences, Inc.
(PCRX)
WILLIAMS KRISTEN
— Chief Administrative Officer
Feb 2, 2026
Sale
Shares
13,137
Price
$20.53
Total Value
$269.70K
Shares Held After
131,303
% of Holdings
9.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Biogen Inc.
(BIIB)
Singhal Priya
— Head of Development
Feb 2, 2026
Sale
Shares
748
Price
$179.30
Total Value
$134.12K
Shares Held After
6,271
% of Holdings
10.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BioAge Labs, Inc.
(BIOA)
RUBIN PAUL D
— Chief Medical Officer
Feb 2, 2026
Sale
Shares
7,433
Price
$18.75
Total Value
$139.37K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Zenas BioPharma, Inc.
(ZBIO)
MOULDER LEON O JR
— Director
Feb 2, 2026
Purchase
Shares
57,000
Price
$17.96
Total Value
$1.02M
Shares Held After
423,155
% of Holdings
13.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
BENKOWITZ MICHAEL
— PRESIDENT AND COO
Feb 2, 2026
Sale
Shares
7,875
Price
$470.95
Total Value
$3.71M
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
UNITED THERAPEUTICS Corp
(UTHR)
BENKOWITZ MICHAEL
— PRESIDENT AND COO
Feb 2, 2026
Sale
Shares
14,625
Price
$470.95
Total Value
$6.89M
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
STRYKER CORP
(SYK)
Pierce James Andrew
— Group President
Feb 2, 2026
Sale
Shares
475
Price
$368.87
Total Value
$175.21K
Shares Held After
70,563
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BOSTON SCIENTIFIC CORP
(BSX)
Mahoney Michael F
— Director
Feb 2, 2026
Sale
Shares
159,701
Price
$93.49
Total Value
$14.93M
Shares Held After
1,411,735
% of Holdings
10.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
BOSTON SCIENTIFIC CORP
(BSX)
Mahoney Michael F
— Director
Feb 2, 2026
Sale
Shares
1,200
Price
$94.06
Total Value
$112.87K
Shares Held After
1,571,436
% of Holdings
0.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Inotiv, Inc.
(NOTV)
Leasure Robert Jr.
— Director
Feb 2, 2026
Sale
Shares
113,297
Price
$0.50
Total Value
$57.03K
Shares Held After
1,273,025
% of Holdings
8.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
RESMED INC
(RMD)
Sandercock Brett
— Chief Financial Officer
Feb 2, 2026
Sale
Shares
1,000
Price
$257.03
Total Value
$257.03K
Shares Held After
85,495
% of Holdings
1.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Serina Therapeutics, Inc.
(SER)
Moreadith Randall
— Chief Scientific Officer
Feb 2, 2026
Sale
Shares
6,500
Price
$3.03
Total Value
$19.68K
Shares Held After
0
% of Holdings
100.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Vir Biotechnology, Inc.
(VIR)
SATO VICKI L
— Director
Feb 2, 2026
Sale
Shares
22,000
Price
$7.71
Total Value
$169.67K
Shares Held After
1,144,391
% of Holdings
1.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Ultragenyx Pharmaceutical Inc.
(RARE)
Horn Howard
— Chief Financial Officer
Feb 2, 2026
Sale
Shares
3,061
Price
$23.56
Total Value
$72.12K
Shares Held After
88,935
% of Holdings
3.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alkermes plc.
(ALKS)
Cooke Shane
— Director
Feb 2, 2026
Sale
Shares
32,113
Price
$34.78
Total Value
$1.12M
Shares Held After
103,744
% of Holdings
23.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alkermes plc.
(ALKS)
Cooke Shane
— Director
Feb 2, 2026
Sale
Shares
29,087
Price
$34.34
Total Value
$998.80K
Shares Held After
135,857
% of Holdings
17.6%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alkermes plc.
(ALKS)
Hopkinson Craig C.
— EVP R&D, Chief Medical Officer
Feb 2, 2026
Sale
Shares
4,000
Price
$33.54
Total Value
$134.16K
Shares Held After
57,740
% of Holdings
6.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Alkermes plc.
(ALKS)
Hopkinson Craig C.
— EVP R&D, Chief Medical Officer
Feb 2, 2026
Sale
Shares
5,000
Price
$34.24
Total Value
$171.22K
Shares Held After
61,740
% of Holdings
7.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Solid Biosciences Inc.
(SLDB)
Herzich Paul
— Chief Technology Officer
Feb 2, 2026
Sale
Shares
26,250
Price
$6.44
Total Value
$168.97K
Shares Held After
79,972
% of Holdings
24.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Solid Biosciences Inc.
(SLDB)
Howton David T
— Chief Operating Officer
Feb 2, 2026
Sale
Shares
37,771
Price
$6.44
Total Value
$243.13K
Shares Held After
116,753
% of Holdings
24.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Solid Biosciences Inc.
(SLDB)
Hanrahan Jessie
— Chief Regulatory Officer
Feb 2, 2026
Sale
Shares
26,535
Price
$6.44
Total Value
$170.80K
Shares Held After
82,675
% of Holdings
24.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Solid Biosciences Inc.
(SLDB)
Brooks Gabriel
— Chief Medical Officer
Feb 2, 2026
Sale
Shares
28,335
Price
$6.44
Total Value
$182.39K
Shares Held After
96,708
% of Holdings
22.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Solid Biosciences Inc.
(SLDB)
Cumbo Alexander
— Director
Feb 2, 2026
Sale
Shares
80,258
Price
$6.44
Total Value
$516.61K
Shares Held After
270,931
% of Holdings
22.9%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Solid Biosciences Inc.
(SLDB)
Tan Kevin
— CFO & Treasurer
Feb 2, 2026
Sale
Shares
26,837
Price
$6.44
Total Value
$172.75K
Shares Held After
108,984
% of Holdings
19.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Axsome Therapeutics, Inc.
(AXSM)
TABUTEAU HERRIOT
— Director
Feb 2, 2026
Sale
Shares
32,410
Price
$185.60
Total Value
$6.02M
Shares Held After
7,229
% of Holdings
81.8%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ABEONA THERAPEUTICS INC.
(ABEO)
Crombez Eric
— Director
Feb 2, 2026
Sale
Shares
16,284
Price
$5.09
Total Value
$82.90K
Shares Held After
63,456
% of Holdings
20.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ABEONA THERAPEUTICS INC.
(ABEO)
Wuchterl Donald A.
— Director
Feb 2, 2026
Sale
Shares
14,814
Price
$5.09
Total Value
$75.41K
Shares Held After
167,935
% of Holdings
8.1%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Xeris Biopharma Holdings, Inc.
(XERS)
Hecht Beth
— Chief Legal Officer and Corporate Secretary
Feb 2, 2026
Sale
Shares
16,667
Price
$7.45
Total Value
$124.15K
Shares Held After
1,243,174
% of Holdings
1.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Fennec Pharmaceuticals Inc.
(FENC)
Raykov Rosty
— Director
Feb 2, 2026
Sale
Shares
10,349
Price
$7.76
Total Value
$80.31K
Shares Held After
98,477
% of Holdings
9.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
InspireMD, Inc.
(NSPR)
Gleason Shane Thomas
— Chief Commercial Officer
Feb 2, 2026
Sale
Shares
2,000
Price
$1.60
Total Value
$3.21K
Shares Held After
1,139,177
% of Holdings
0.2%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Clene Inc.
(CLNN)
Ugwumba Chidozie
— 10% Owner
Feb 2, 2026
Sale
Shares
3,800
Price
$4.04
Total Value
$15.35K
Shares Held After
555,559
% of Holdings
0.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ZEVRA THERAPEUTICS, INC.
(ZVRA)
McFarlane Neil F.
— Director
Feb 2, 2026
Sale
Shares
91,000
Price
$9.38
Total Value
$853.43K
Shares Held After
364,350
% of Holdings
20.0%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ABEONA THERAPEUTICS INC.
(ABEO)
Alland Leila
— Director
Feb 2, 2026
Sale
Shares
18,065
Price
$5.09
Total Value
$91.96K
Shares Held After
173,614
% of Holdings
9.4%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
ABEONA THERAPEUTICS INC.
(ABEO)
Alvino Mark
— Director
Feb 2, 2026
Sale
Shares
2,000
Price
$5.09
Total Value
$10.18K
Shares Held After
84,065
% of Holdings
2.3%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
Neogen Corporation
(NEOG)
Nassif Mikheal
— Director
Feb 2, 2026
Purchase
Shares
24
Price
$10.00
Total Value
$239.99
Shares Held After
681
% of Holdings
3.5%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
CYTOKINETICS INC
(CYTK)
Callos Andrew
— EVP, Chief Commercial Officer
Feb 2, 2026
Sale
Shares
886
Price
$62.10
Total Value
$55.02K
Shares Held After
50,440
% of Holdings
1.7%
View Filing
📈 Chart on TradingView
💰 Financials on Finviz
← Previous
Showing 1551–1586 of 1586 transactions (page 32 of 32)
Version: v26.3.33